Talking the talk

Are biotechs underestimating regulatory groundwork

Major update aims to accelerate research and strengthen patient safety New UK clinical trials regulations have been signed into law, with a 12-month rollout starting […]

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Moderna has received marketing authorisation from the European Commission for its updated COVID-19 vaccine, Spikevax, […]